Unique ID issued by UMIN | UMIN000024836 |
---|---|
Receipt number | R000028581 |
Scientific Title | Evaluation of the effect of compression therapy by using surgical gloves on nab-paclitaxel-induced peripheral neuropathy in primary breast cancer patients:a phase 3 multicenter study (single-armed study) |
Date of disclosure of the study information | 2016/11/14 |
Last modified on | 2019/05/18 15:39:16 |
Evaluation of the effect of compression therapy by using surgical gloves on nab-paclitaxel-induced peripheral neuropathy in primary breast cancer patients:a phase 3 multicenter study (single-armed study)
Evaluation of the effect of compression therapy by using surgical gloves on nab-paclitaxel-induced peripheral neuropathy:a phase 3 multicenter study
Evaluation of the effect of compression therapy by using surgical gloves on nab-paclitaxel-induced peripheral neuropathy in primary breast cancer patients:a phase 3 multicenter study (single-armed study)
Evaluation of the effect of compression therapy by using surgical gloves on nab-paclitaxel-induced peripheral neuropathy:a phase 3 multicenter study
Japan |
Breast cancer
Breast surgery |
Malignancy
NO
The evaluation of the effect of compression therapy by surgical gloves for prevention of nab-paclitaxel-induced peripheral
neuropathy.
Safety,Efficacy
Confirmatory
Phase III
Occurrence of nab-paclitaxel-induced peripheral neuropathy of grade 2 or higher
1) The evaluation of nab-paclitaxel-induced PN by using the Patient Neurotoxicity Questionnaire (we call PNQ)
2) The changes in the temperature of each fingertip
3) Withdrawal rate of wearing sutgical gloves
4) Adverse events of wearung surgical gloves
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Prevention
Device,equipment |
wear two surgical gloves of the same size on both hands
20 | years-old | <= |
75 | years-old | >= |
Female
1)Histologically orcytologically confirmed invasive breast cancer
2) Considered eligible to neoadjuvant
chemotherapy or adjuvant chemotherapy
3)ECOG performance status 0-1
4)No peripheral sensory / motor neuropathy (CTCAE ver4.0)
5)Adequate organ function, Adequate organ function
6)Signed written informed consent
1)have any peripheral sensory / motor neuropathy (CTCAE ver4.0)
2)received previous chemotherapy
3) Multiple primary cancer. However,
carcinoma in situ can be cured by local
treatment is not included in multiple
primary cancer
4) Synchronous bilateral breast cancer
5) Brain metastasis
6) Poorly controlled complication (infection, diabetes mellitus, and others)
57
1st name | Shigeru |
Middle name | |
Last name | Tsuyuki |
Osaka Red Cross Hospital
Department of Breast Surgery
543-8555
5-30 Fudegasaki-cho, Tennoji-ku, Osaka, Japan
06-6774-5111
tyksgr@osaka-med.jrc.or.jp
1st name | Shigeru |
Middle name | |
Last name | Tsuyuki |
Osaka Red Cross Hospital
Department of Breast Surgery
543-8555
5-30 Fudegasaki-cho, Tennoji-ku, Osaka, Japan
06-6774-5111
tyksgr@osaka-med.jrc.or.jp
Kamigata Breast Cancer Study Group
none
Self funding
Medical Ethics Review Committee, Osaka Red Cross Hospital
5-30 Fudegasaki-cho, Tennoji-ku, Osaka, Japan
06-6774-5111
soumuka@osaka-med.jrc.or.jp
NO
2016 | Year | 11 | Month | 14 | Day |
Unpublished
61
Completed
2016 | Year | 09 | Month | 30 | Day |
2016 | Year | 10 | Month | 01 | Day |
2016 | Year | 10 | Month | 15 | Day |
2019 | Year | 03 | Month | 31 | Day |
2019 | Year | 03 | Month | 31 | Day |
2016 | Year | 11 | Month | 14 | Day |
2019 | Year | 05 | Month | 18 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028581